Skip to content

APHARMAT

Active Private limited companyfounded 2010active for 15 yearsVan Eycklei 47, 2018 AntwerpKBO/BCE: BE 0831.853.489 subsidiary of

Board

1 director, no change since September 2026
Director (not named in the articles), permanent representative
since 01-04-2020 term without a fixed end
listed in the 2025 annual accounts, filed on 15-07-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each manager alone
deed of 23-12-2010
Permanent representatives 1
Permanent representative, for
appointed by deed of 09-07-2020

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Director (not named in the articles)
Board
Mandates as a list
    • Director (not named in the articles), from 01-04-2020 to date
With Starter you also see 7 former office holders in the mandate history. See the plans →

Control

Parent
Equity €748,258
Profit €34,519 in 2025 (profit €28,486 in 2024)
Checked score
Source: accounts 2025
100%
This company
APHARMAT
Equity €49,674
Profit €52,995 in 2025

Capital

Contribution
€6,200
Shares
186
Contribution per share
€33.33
Equity per share
€267 in 2025
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
100%
Owners as a list

Source: parent in its own accounts, lists of holdings in the owners' accounts

Articles of association

DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 09-07-2020 (in Dutch)
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
Voorafgaande bijzondere en geschreven toestemming van alle vennoten, nietigheid
deed of 23-12-2010 (in Dutch)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Wednesday of June at 20:00
deed of 23-12-2010 (in Dutch)

Capital transactions

Shareholders according to the deeds
At incorporation deed of 23-12-2010 ↗
  • founder
  • founder
Capital over time
  1. 09-07-2020 Converted to unavailable equity
  2. 20-01-2016 Capital stated in the deed · €18,600 · 186 shares
  3. 23-12-2010 Incorporation · €18,600 · 186 shares

Next steps